Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 20 for “"Ifosfamide"”.
-
Solid Lipid Nanoparticulate Formulation for ifosfamide: Development and Characterization
… and characterization of a delivery system for ifosfamide to enhance its stability and sustaining in vitro release. Solid lipid nanoparticles (SLNs) of ifosfamide were developed by double emulsion solvent evaporation technique using glyceryl monooleate and chitosan. The chitosan present in the …
-
Oxidation of pharmaceuticals : impacts of natural organic matter and elimination of residual pharmacological activity
… cyclophosphamide, erythromycin, and ifosfamide. Ciprofloxacin and erythromycin are antibiotic/antimicrobial compounds, and cyclophosphamide and ifosfamide are chemotherapy agents. Ozone effectively transformed all four pharmaceuticals, even in the presence of background natural …
-
Sequentielle Gabe von Hochdosismethotrexat- und Hochdosiscytarabin-basierter Polychemotherapie bei älteren Patienten mit primärem ZNS-Lymphom
… Rituximab 375mg/m2 d1, HDMTX 4g/m2 d2 and Ifosfamide 800 mg/m2 d4-6 (induction) and 2 courses HDAraC 3g/m2 d1-2 and one course HDMTX+ Ifosfamide in between (consolidation); one additional course could have been given optionally. Results: The therapy planned (a total of ≥ 6 courses) were …
-
Fertility in childhood cancer survivors
… doxorubicin and the alkylating agents ifosfamide and cyclophosphamide. Results of my work with doxorubicin aimed to investigate the effect of repeated exposures to a chemotherapy drug, given that this is how these drugs are administered in practice. Results showed no significant …
-
Σαρκώματα γυναικείου γεννητικού συστήματος
… Seventeen (54.8%) patients received namely ifosfamide, etoposide and epirubicin, 6 (19.4%) patients were treated with doxorubicin and carboplatin, doxorubicin and ifosfamide was administered to 3 (9.6%) patients, while 5 (16.1%) patients received various anthracycline-based regimens. With a …
-
Μελέτη προγνωστικών και προβλεπτικών παραγόντων στον προχωρημένο ή μεταστατικό καρκίνο του τραχήλου της μήτρας που αντιμετωπίζεται με χημειοθεραπεία
… in a phase II trial of cisplatin and ifosfamide, with or without paclitaxel were collected for retrograde analysis. Immunohistochemistry and genotyping was performed totest ERCC1, III β-tubulin, COX-2, CD4, CD8 and ERCC1 (C8092A and N118 N) and MDR1 (C3435T and G2677 T) gene …
-
Ανάπτυξη μεθόδων προσδιορισμού φαρμάκων με ιοντική χρωματογραφία
… antineoplastic alkylating agents like ifosfamide and cyclophosphamide. The results revealed that the methods are suitable for the determination of ionic organic compounds in commercial pharmaceutical formulations. Advantages of the proposed methods include the absence of derivatization …
-
Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία
… analyzed in relation toresponse to Paclitaxel-Ifosfamide-Cisplatin (TIP) chemotherapy.Methods Freshly isolated lung tumour specimens from 35 NSCLC chemotherapy naïvepatients were sampled and analysed for vascular endothelial growth factor receptor-1(VEGFR-1), VEGFR-2 and VEGFR-3, Tumor necrosis …
-
Η έκφραση των πρωτεϊνών Π-γλυκοπρωτεϊνης (P-gp) και της τρανσφεράσης-s της γλουταθειόνης-π (GST-π) σε κυτταρολογικά παρασκευάσματα ασθενών με καρκίνο του πνεύμονα: ο ρόλος αυτής της έκφρασης στην απάντηση στην χημειοθεραπεία
… antineoplastic treatment with cis-platin, ifosfamide and vinblastine, SCLC patients treatment with Carboplatin and Etoposide. All patients were reevaluated for treatment response. The expression of GST-pi and P-gp was evaluated immunohistochemically in cytology specimens and in both …
-
Mechanistic Studies of the Transcription Inhibitor Triptolide and its Selective Targeting to Cancer Cells under Hypoxia
… to target cancer cells as seen with paclitaxel, ifosfamide and platinum. We decided to focus on glucose-conjugated triptolides (glutriptolides) given the specificity and potent antiproliferative activity of triptolide in addition to promising in vivo anti- tumor activity of a recently identified …
-
Uncovering and exploiting biological vulnerabilities in synovial sarcoma
… disease. First line treatments, doxorubicin and ifosfamide, elicit only temporary responses while conferring high toxicities. Second line therapies, pazopanib and trabectedin, yield partial responses in only 10-20% of patients. Despite multimodal treatment, recurrences are common, with 5-year …
-
Investigating the Cytotoxic Mechanisms of Hepatotoxicity Induced by Xenobiotics and their Metabolites
… of anticancer agents cyclophosphamide/ifosfamide, and the subsequent protective capacities of various protecting agents in both cell- and cell-free models. This study could provide a better understanding into the therapeutic value of protective agents currently being prescribed and …
-
Monitoring of occupational exposure to antineoplastic drugs
… teratogenic to humans. Cyclophosphamide (CP) and ifosfamide (IF) are two common antineoplastic drugs. The general aim of this thesis was to develop and evaluate methods for monitoring of exposure to antineoplastic drugs. Methods for determination of surface contamination and air sampling, both as …
-
Investigating the occurrence and fate of anticancer drugs in sewage treatment works and the wider aquatic environment
… used anticancer drugs, cyclophosphamide (CP) and ifosfamide (IF) in wastewater and river water; to assess the performance of a river-based chemical fate model through comparisons with field observations; and to conduct a mass balance for CP in wastewater treatment plants to assess chemical fate …
-
Roles of TNS3 gene in tumor progression of Neurofibromatosis Type 1
… reduced. Co-treatment of TNS3 shRNA and ifosfamide, carboplatin, and etoposide (ICE) or cisplatin, vinblastine, and methotrexate (CVM) anticancer drugs significantly increased the caspase-3 cleavage and apoptotic cell death, but it decreased Ras and ERK1/2 activation, indicating that TNS3 …
-
Kombinationschemotherapie mit Cisplatin, Etoposid und Ifosfamid als Salvagetherapie bei Patientinnen mit metastasiertem Mammakarzinom
Einleitung: Das Mammakarzinom stellt mit etwa 25% aller malignen Primärtumoren das häufigste Malignom des weiblichen Geschlechtes dar. Trotz neuer Behandlungsoptionen und einer Zunahme der zielgerichteten und individualisierten Therapiemöglichkeiten haben Patientinnen mit metastasiertem …
-
Therapeutic targets in dedifferentiated liposarcoma
… of their paired clinical tumors. Cabazitaxel and ifosfamide resulted in the highest maximum tumor volume inhibition. MDM2 inhibition with milademetan resulted in different effects in the two analyzed models, which were higher in LS-MP compared to LS-NV. Conversely, the AURKA inhibitor prexasertib …
-
Ο ρόλος της χημειοθεραπείας διάσωσης σε ασθενείς με τοπικά εκτεταμένο και μεταστατικό μη-μικροκυτταρικό καρκίνο του πνεύμονος: μελέτη των παραγόντων που επηρεάζουν την επιβίωση των ασθενών μετά τη χημειοθεραπεία 1ης γραμμής
… (BSC) ή τη μονοθεραπεία με vinorelbine ή ifosfamide. Επιπλέον, οι ασθενείς που έλαβανDocetaxel αποδεδειγμένα εμφάνισαν βελτίωση της κλινικής τους εικόνας και της ποιότητας ζωήςτους. Τέλος, μια μεγάλη τυχαιοποιημένη μελέτη στην οποία συγκρίθηκε η μονοθεραπεία μεDocetaxel με τη μονοθεραπεία …
-
Συνδυασμός σισπλατίνης, ιφωσφαμίδης, μεθοτρεξάτης και βιμπλαστίνης στο μεταστατικό καρκίνο των ουροφόρων οδών.
ΣΚΟΠΟΣ ΤΗΣ ΕΡΓΑΣΙΑΣ ΗΤΑΝ Η ΜΕΛΕΤΗ ΤΗΣ ΑΠΟΤΕΛΕΣΜΑΤΙΚΟΤΗΤΑΣ ΚΑΙ ΤΟΞΙΤΟΤΗΤΑΣ ΤΟΥ ΧΗΜΕΙΟΘΕΡΑΠΕΥΤΙΚΟΥ ΣΥΝΔΥΑΣΜΟΥ ΣΙΣΠΛΑΤΙΝΗΣ,ΙΦΩΣΦΑΜΙΔΗΣ, ΜΕΘΟΤΡΕΞΑΤΗΣ ΚΑΙ ΒΙΝΜΠΛΑΣΤΙΝΗΣ ΣΕ ΑΣΘΕΝΕΙΣ ΜΕ ΜΕΤΑΣΤΑΤΙΚΟ ΚΑΡΚΙΝΟ ΤΟΥ ΟΥΡΟΘΗΛΙΟΥ.Η ΚΥΡΙΩΤΕΡΗ ΕΚΔΗΛΩΣΗ ΤΟΞΙΚΟΤΗΤΑΣ ΗΤΑΝ Η ΟΥΔΕΤΕΡΟΠΕΝΙΑ ΣΕ 56% ΤΩΝ ΑΣΘΕΝΩΝ ΚΑΙ …